Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02194725 · ClinicalTrials.gov registry record

Where Does Hope Fit In? The Relationship Between Hope, Uncertainty, and Coping Efficacy in Mothers of Children With Duchenne/Becker Muscular Dystrophy

A clinical trial, sponsored by National Human Genome Research Institute (NHGRI).

Completed
Registry status
228
Enrollment target

NCT02194725 is a clinical trial that has completed, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 228 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02194725 has completed, sponsored by National Human Genome Research Institute (NHGRI).

COMPLETED
Registry status
228 participants
Enrollment target

Study Summary

Background: \- Children with Duchenne/Becker Muscular Dystrophy (DBMD) slowly lose muscle function. They usually die at a young age. Some mothers adapt to the demands of caring for a child with this disease better than others. Studies show that a person s hope may positively affect how they cope and adapt. Researchers want to find out more about this. They want to develop ways to improve caregivers overall wellness. Objective: \- To study the relationships between uncertainty, hope, and coping ability in mothers of children with DBMD. Eligibility: \- Women in the United States 18 years and older. They must be biological mothers of a living child with DBMD and be able to answer a survey in English. Design: * This study is part of a larger study that examines the well-being of mothers with sons who have DBMD. * Participants will take a questionnaire. The questionnaire can be done on paper or on a computer. It will take 30 45 minutes to complete. * The questionnaire will include basic demographic questions about the participant and the child. There will also be questions about how the participant copes with the stress and uncertainty of DBMD. * For most of the questions, participants will rate their feelings on a scale. There will also be four open-ended questions.

Trial Details

FieldValue
Enrollment Target 228 participants
Start Date 2014-07-06
Est. Completion 2017-07-07

What the Registry Record Tells You About NCT02194725

The ClinicalTrials.gov registry entry for NCT02194725 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 228 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Human Genome Research Institute (NHGRI), which has 185 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT02194725 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02194725 about?

NCT02194725 is a clinical study titled "Where Does Hope Fit In? The Relationship Between Hope, Uncertainty, and Coping Efficacy in Mothers of Children With Duchenne/Becker Muscular Dystrophy". Background: \- Children with Duchenne/Becker Muscular Dystrophy (DBMD) slowly lose muscle function. They usually die at a young age. Some mothers adapt to the demands of caring for a child with this disease better than others. Studies show that a person s hope may positively affect how they cope an...

What is the current status of trial NCT02194725?

This trial is currently completed. The enrollment target is 228 participants. The study started on 2014-07-06. Estimated completion is 2017-07-07.

Who is sponsoring clinical trial NCT02194725?

This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.